Teva Pharma has settled a suit seeking to block Dr. Reddy’s Lab from launching a generic version of GlaxoSmithKline's congestive heart failure drug Carvedilol. The lawsuits concern US6699997, US6710184, US7056942 and US7126008 all of which are owned by Teva and covers Carvedilol API. Earlier, in Junuary 2008, Teva settled with Taro over above patents. The Teva is still in litigation with Apotex and Zydus on these patents
Friday, 1 August 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment